Intensified glucose lowering in type 2 diabetes: Time for a bolder reappraisal

Diabetologia

Volumn 54, Issue 3, 2011, Pages 701-702

  Czupryniak, L ^a   Szymanska Garbacz E ^a   Pawlowski M ^a   Saryusz Wolska, M ^a   Loba, J ^a  

^a N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

Author keywords

Diabetes complications; Intensive glucose lowering; Prevention; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; INDAPAMIDE PLUS PERINDOPRIL;

AGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DRUG TARGETING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LETTER; LIFE EXPECTANCY; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS;

EID: 79953063505     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2011-6     Document Type: Letter

References (7)

1. Yudkin JS, Richter B, Gale EAM (2010) Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 53:2079-2085
2. The Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
3. Duckworth W, Abraira C, Moritz T, for the VADT Investigators et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129-139
4. Riddle MC, Ambrosius WT, Brillon DJ et al (2010) Epidemiologic relationships between A1c and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diab Care 33:983-990
5. American Diabetes Association (2010) Factors affecting benefit/harm of intensive glucose control in type 2 diabetes reported. Available from http://professional.diabetes.org/Congress-Display.aspx?TYP=9&SID= 244&CID=60976, accessed 1 October 2010
6. Turnbull FM, Abraira C, Anderson RJ et al (2009) Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52:2288-2298, Erratum 52: 2470
7. Greenfield S, Billimek J, Pellegrini F et al (2009) Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 151:854-860